FIREBIRD BIOMOLECULAR SCIENCES LLC
Expanded genetic alphabet DNA synthesis platform using artificial nucleotides for autonomous assembly of large DNA constructs
- Sector
- Biotech
- Headquarters
- Alachua, FL
- Total capital
- $10.8M
- Federal grants
- $9.4M
- 26 awards · 2014–2024
- Rank in peer group#181 of 514
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $1.4M
- 6 awards · Defense, Health and Human S, Interior
- Rank in Biotech#157 of 4373
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Federal grantDefense · Phase I · Dha SBIR Phase 1 Proposal H242-001-0085, "innovative Dna For Highly Multiplexed Molecular Diagnostics"$250K
- Federal contractDefense · Dha SBIR Phase 1 Proposal H242-001-0085, "innovative Dna For Highly Multiplexed Molecular Diagnostics"$250K
- Federal grantHealth and Human S · Phase II · PHS2019-02 Omnibus Solic of the NIH, CDC, and FDA for SBIR Apps No Clinical Trial (Parent SBIR R43/4$485K
- Federal grantEnergy · Phase I · TRL 4 Demonstration of the Synthesis of 10,000+ Nucleotide Pair Constructs with Per-Base Error < 0.0001$250K
- Federal grantHealth and Human S · Phase II · Field Detection of arboviruses directly from mosquito traps Firebird Biomolecular Sciences, LLC$972K
- Federal grantHealth and Human S · Phase II · PHS2019-02 Omnibus Solic of the NIH, CDC, and FDA for SBIR Apps No Clinical Trial (Parent SBIR R43/4$487K
- Federal grantHealth and Human S · Phase I · Reagents to Chemically Tag Specific Coronavirus Spike Proteins$259K
Show 25 earlier federal awards
- Federal grantHealth and Human S · Phase II · Create Ultralong DNA Constructs in One Assembly Step$648K
- Federal grantHealth and Human S · Phase II · Create Ultralong DNA Constructs in One Assembly Step$1.3M
- Federal grantHealth and Human S · Phase II · Create Ultralong DNA Constructs in One Assembly Step$648K
- Federal grantHealth and Human S · Phase II · Receptors, Ligands, and Catalysts on Demand using Expanded Genetic Alphabets$491K
- Federal grantHealth and Human S · Phase I · Synthetic Biology for Field Detection of Zika in the US and Abroad$150K
- Federal grantHealth and Human S · Phase II · Receptors, Ligands, and Catalysts on Demand using Expanded Genetic Alphabets$990K
- Federal grantHealth and Human S · Phase II · Receptors, Ligands, and Catalysts on Demand using Expanded Genetic Alphabets$500K
- Federal contractInterior · Igf::ot::igf Real-time Assessment Of Antimicrobial Concentrations For Personalized Treatment Of Infectious Diseases$100K
- Federal grantDefense · Phase I · Real-time Assessment of Antimicrobial Concentrations for Personalized Treatment of Infectious Diseases$150K
- Federal grantHealth and Human S · Phase I · Commercial Polymerases to Create Receptors, Ligands, and Catalysts on Demand$136K
- Federal grantHealth and Human S · Phase I · Commercial Polymerases to Create Receptors, Ligands, and Catalysts on Demand$136K
- Federal grantHealth and Human S · Phase I · Reagents to Create Large DNA Constructs in One Assembly Step$150K
- Federal grantHealth and Human S · Phase I · Reagents to Create Large DNA Constructs in One Assembly Step$150K
- Federal grantHealth and Human S · Phase I · Eliminating Malaria from Haiti. Reinventing DNA to Eradicate Endemic Parasites$147K
- Federal grantHealth and Human S · Phase I · Eliminating Malaria from Haiti. Reinventing DNA to Eradicate Endemic Parasites$147K
- Federal grantHealth and Human S · Phase I · Kits for high-multiplexed detection of RNA viruses in complex biological samples$150K
- Federal grantHealth and Human S · Phase I · Kits for high-multiplexed detection of RNA viruses in complex biological samples$150K
- Federal grantHealth and Human S · Phase I · Receptors, Ligands, and Catalysts on Demand using Expanded Genetic Alphabets$150K
- Federal grantHealth and Human S · Phase I · Receptors, Ligands, and Catalysts on Demand using Expanded Genetic Alphabets$150K
- Federal grantHealth and Human S · Phase I · Simple Inexpensive Assay for Five Common HIV Resistance Mutations$170K
- Federal grantHealth and Human S · Phase I · Simple Inexpensive Assay for Five Common HIV Resistance Mutations$170K
- Federal contractDefense · Igf::ot::igf Army Phase I Proposal A141-049-0858$100K
- Federal contractHealth and Human S · SBIR Phase I Igf::ot::igf$150K
- Federal contractDefense · Technical Progress Report$750K
- Federal contractDefense · Second Progress Report -$100K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grants#181 · top 35%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- PRESSURE BIOSCIENCES, INC.Similar federal contract value in Biotech · $1.6M in contracts
- SOLARIS VACCINES, INC.Similar federal contract value in Biotech · $1.5M in contracts
- Arytha Biosciences, LLCSimilar federal contract value in Biotech · $1.5M in contracts
- Cofactor Genomics, Inc.Similar federal contract value in Biotech · $1.4M in contracts
- BLOOD CELL STORAGE INCSimilar federal contract value in Biotech · $1.4M in contracts
- GLYCOSCIENTIFIC, L.L.C.Similar federal contract value in Biotech · $1.4M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .